These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 18349872

  • 1. Substance abuse in pregnant women: making improved detection a good clinical outcome.
    Araojo R, McCune S, Feibus K.
    Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872
    [Abstract] [Full Text] [Related]

  • 2. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
    Koren G, Hutson J, Gareri J.
    Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
    [Abstract] [Full Text] [Related]

  • 3. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM, Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V, Ager J.
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [Abstract] [Full Text] [Related]

  • 4. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
    Wingert WE, Feldman MS, Kim MH, Noble L, Hand I, Yoon JJ.
    J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
    [Abstract] [Full Text] [Related]

  • 5. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.
    Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD.
    J Perinatol; 2006 Jan 01; 26(1):11-4. PubMed ID: 16281047
    [Abstract] [Full Text] [Related]

  • 6. Opioid detection in maternal and neonatal hair and meconium: characterization of an at-risk population and implications to fetal toxicology.
    Moller M, Karaskov T, Koren G.
    Ther Drug Monit; 2010 Jun 01; 32(3):318-23. PubMed ID: 20418801
    [Abstract] [Full Text] [Related]

  • 7. Hair analysis of fatty acid ethyl esters in the detection of excessive drinking in the context of fetal alcohol spectrum disorders.
    Kulaga V, Pragst F, Fulga N, Koren G.
    Ther Drug Monit; 2009 Apr 01; 31(2):261-6. PubMed ID: 19258930
    [Abstract] [Full Text] [Related]

  • 8. Drugs of abuse testing in meconium.
    Gareri J, Klein J, Koren G.
    Clin Chim Acta; 2006 Apr 01; 366(1-2):101-11. PubMed ID: 16413011
    [Abstract] [Full Text] [Related]

  • 9. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke.
    Chan D, Caprara D, Blanchette P, Klein J, Koren G.
    Clin Biochem; 2004 Jun 01; 37(6):429-38. PubMed ID: 15183290
    [Abstract] [Full Text] [Related]

  • 10. Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population.
    Shor S, Nulman I, Kulaga V, Koren G.
    Alcohol; 2010 Jun 01; 44(7-8):623-7. PubMed ID: 20031369
    [Abstract] [Full Text] [Related]

  • 11. Hair analysis for drug detection.
    Kintz P, Villain M, Cirimele V.
    Ther Drug Monit; 2006 Jun 01; 28(3):442-6. PubMed ID: 16778731
    [Abstract] [Full Text] [Related]

  • 12. In utero drugs of abuse exposure testing for newborn twins.
    Wang P, Molina CP, Maldonado JE, Bernard DW.
    J Clin Pathol; 2010 Mar 01; 63(3):259-61. PubMed ID: 20203227
    [Abstract] [Full Text] [Related]

  • 13. Measuring prenatal drug exposure.
    Bergin C, Cameron CE, Fleitz RS, Patel AV.
    J Pediatr Nurs; 2001 Aug 01; 16(4):245-55. PubMed ID: 11498817
    [Abstract] [Full Text] [Related]

  • 14. A simple method to identify alcohol and other drug use in pregnant adults in a prenatal care setting.
    Hinderliter SA, Zelenak JP.
    J Perinatol; 1993 Aug 01; 13(2):93-102. PubMed ID: 8390571
    [Abstract] [Full Text] [Related]

  • 15. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy.
    Lendoiro E, González-Colmenero E, Concheiro-Guisán A, de Castro A, Cruz A, López-Rivadulla M, Concheiro M.
    Ther Drug Monit; 2013 Jun 01; 35(3):296-304. PubMed ID: 23666580
    [Abstract] [Full Text] [Related]

  • 16. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine.
    Casanova OQ, Lombardero N, Behnke M, Eyler FD, Conlon M, Bertholf RL.
    Arch Pathol Lab Med; 1994 Oct 01; 118(10):988-93. PubMed ID: 7944901
    [Abstract] [Full Text] [Related]

  • 17. Detection of prenatal drug exposure in the pregnant women and her newborn infant.
    Ostrea EM, Welch RA.
    Clin Perinatol; 1991 Sep 01; 18(3):629-45. PubMed ID: 1934859
    [Abstract] [Full Text] [Related]

  • 18. Emerging biomarkers of intrauterine neonatal and pediatric exposures to xenobiotics.
    Delano K, Koren G.
    Pediatr Clin North Am; 2012 Oct 01; 59(5):1059-70. PubMed ID: 23036244
    [Abstract] [Full Text] [Related]

  • 19. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island.
    Friguls B, Joya X, Garcia-Serra J, Gómez-Culebras M, Pichini S, Martinez S, Vall O, Garcia-Algar O.
    Addiction; 2012 Aug 01; 107(8):1471-9. PubMed ID: 22296208
    [Abstract] [Full Text] [Related]

  • 20. Gastric fluid analysis for determining gestational cocaine exposure.
    Garcia DC, Romero A, Garcia GC, Ostrea EM.
    Pediatrics; 1996 Aug 01; 98(2 Pt 1):291-3. PubMed ID: 8692634
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.